Efficacy and Safety of LP-005 Injection in Patients With Moderate-to-Severe Periodontitis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical study designed to evaluate the clinical efficacy, safety, pharmacokinetics, pharmacodynamics, and immunogenicity of multiple local injections of different doses of LP-005 injection in patients with moderate-to-severe periodontitis, and to investigate changes in biomarker levels.
Epistemonikos ID: 46be5e370021bd225b1f45493783eede41b653c0
First added on: May 23, 2026